Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | DBH | P09172 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22492290 | 0.83 | SLC6A3 (0.49) | SIGMAR1 | |
| SCHEMBL6115121 | 0.77 | BDKRB2 (0.45) | HTTSMN1; SMN2ALDH1A1BRD4KDM4E | |
| SCHEMBL11275611 | 0.77 | BRD4 (0.57) | HTTSMN1; SMN2TSHRLMNARAB9A | |
| SCHEMBL31163710 | 0.77 | HTR2C (0.44) | HTR2CHTR2B | |
| SCHEMBL1757157 | 0.73 | HPGD (0.50) | HTTLMNAALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL7496406 | 0.73 | ACHE (0.39) | HTTSMN1; SMN2TSHRLMNARAB9A | |
| SCHEMBL18255472 | 0.73 | BDKRB2 (0.45) | HTTSMN1; SMN2LMNAALDH1A1BRD4 | |
| SCHEMBL12951913 | 0.72 | F2 (0.44) | HTTSMN1; SMN2ALDH1A1KDM4EHPGD | |
| SCHEMBL13145555 | 0.72 | BRD4 (0.46) | HTTSMN1; SMN2ALDH1A1BRD4KDM4E | |
| SCHEMBL22408630 | 0.68 | PTGS2 (0.38) | SMN1; SMN2TSHRLMNAALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11422403-B2 | Squarylium compounds for use in display devices | NITTO DENKO CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| US-20200369889-A1 | SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES | NITTO DENKO CORPORATION (JP) | 2020-11-26 | — | — | US | disclosed |
| EP-3717572-A2 | SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES | Nitto Denko Corporation (JP) | 2020-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11422403-B2 | Squarylium compounds for use in display devices | SQLE, SPR, SYMPK | HTT 1469/4885SMN1; SMN2 519/4885TSHR 4154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.